Hims Hers Health Stock Today
| HIMS Stock | USD 30.34 0.34 1.11% |
Performance15 of 100
| Odds Of DistressLess than 40
|
Hims Hers is selling for under 30.34 as of the 28th of November 2024; that is 1.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 30.03. Hims Hers has about a 40 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Hims Hers Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 13th of September 2019 | Category Consumer Defensive | Classification Health Care |
Hims Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company has 210.1 M outstanding shares of which 39.52 M shares are currently shorted by private and institutional investors with about 2.17 trading days to cover. More on Hims Hers Health
Moving together with Hims Stock
Moving against Hims Stock
Hims Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Consumer Defensive, NYSE Composite, SP Small-Cap 600, Housewares, Healthcare, Health Care, Health Care Providers & Services, Household & Personal Products, Consumer Defensive (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsHims Hers can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hims Hers' financial leverage. It provides some insight into what part of Hims Hers' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hims Hers Health (HIMS) is traded on New York Stock Exchange in USA. It is located in 2269 Chestnut Street, San Francisco, CA, United States, 94123 and employs 1,046 people. Hims Hers is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.7 B. Hims Hers Health conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 210.1 M outstanding shares of which 39.52 M shares are currently shorted by private and institutional investors with about 2.17 trading days to cover.
Hims Hers Health currently holds about 194.98 M in cash with 73.48 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94.
Check Hims Hers Probability Of Bankruptcy
Ownership AllocationHims Hers Health has a total of 210.1 Million outstanding shares. Over half of Hims Hers' outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Hims Ownership Details
Hims Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2024-06-30 | 2.6 M | |
| Bank Of America Corp | 2024-06-30 | 2.5 M | |
| Connor Clark & Lunn Inv Mgmt Ltd | 2024-06-30 | 2.3 M | |
| Divisadero Street Capital Management, Lp | 2024-09-30 | 2.3 M | |
| Goldman Sachs Group Inc | 2024-06-30 | 2.2 M | |
| Marshall Wace Asset Management Ltd | 2024-06-30 | 2.2 M | |
| Millennium Management Llc | 2024-06-30 | 2 M | |
| Citadel Advisors Llc | 2024-09-30 | 1.9 M | |
| Foresite Capital Management V, Llc | 2024-09-30 | 1.8 M | |
| Vanguard Group Inc | 2024-09-30 | 18.2 M | |
| Blackrock Inc | 2024-06-30 | 14.6 M |
Hims Hers Historical Income Statement
Hims Stock Against Markets
Hims Hers Corporate Management
| Brian OShaughnessy | Chief Officer | Profile | |
| Peter MD | Senior Board | Profile | |
| Jonathan CFA | VP Relations | Profile | |
| Mike Chi | Chief Officer | Profile | |
| Soleil JD | Chief Secretary | Profile | |
| MD FAAD | VP Board | Profile | |
| Yemi Okupe | Chief Officer | Profile |
Additional Tools for Hims Stock Analysis
When running Hims Hers' price analysis, check to measure Hims Hers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hims Hers is operating at the current time. Most of Hims Hers' value examination focuses on studying past and present price action to predict the probability of Hims Hers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hims Hers' price. Additionally, you may evaluate how the addition of Hims Hers to your portfolios can decrease your overall portfolio volatility.